Home Cart 0 Sign in  

[ CAS No. 6136-68-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 6136-68-1
Chemical Structure| 6136-68-1
Structure of 6136-68-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 6136-68-1 ]

Related Doc. of [ 6136-68-1 ]

Alternatived Products of [ 6136-68-1 ]

Product Details of [ 6136-68-1 ]

CAS No. :6136-68-1 MDL No. :MFCD00001806
Formula : C9H7NO Boiling Point : -
Linear Structure Formula :- InChI Key :SBCFGFDAZCTSRH-UHFFFAOYSA-N
M.W : 145.16 Pubchem ID :80222
Synonyms :

Calculated chemistry of [ 6136-68-1 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.11
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 41.35
TPSA : 40.86 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.36 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.57
Log Po/w (XLOGP3) : 1.16
Log Po/w (WLOGP) : 1.76
Log Po/w (MLOGP) : 1.08
Log Po/w (SILICOS-IT) : 2.14
Consensus Log Po/w : 1.54

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.81
Solubility : 2.26 mg/ml ; 0.0155 mol/l
Class : Very soluble
Log S (Ali) : -1.61
Solubility : 3.54 mg/ml ; 0.0244 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.8
Solubility : 0.232 mg/ml ; 0.0016 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.31

Safety of [ 6136-68-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302+H312+H332-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 6136-68-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 6136-68-1 ]
  • Downstream synthetic route of [ 6136-68-1 ]

[ 6136-68-1 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 6136-68-1 ]
  • [ 105-58-8 ]
  • [ 62088-13-5 ]
YieldReaction ConditionsOperation in experiment
96% With hydrogenchloride In tetrahydrofuran; mineral oil Part A.
Preparation of ethyl 3-(3-cyanophenyl)-3-oxopropionate.
To a suspension of sodium hydride (1.2 g of 60percent suspension in mineral oil, hexane-washed, 30.3 mmol) in 40 mL of tetrahydrofuran was added diethyl carbonate (3.7 mL, 30.3 mmol) and 3-acetyl benzonitrile (2.2 g, 15.2 mmol).
The resulting suspension was stirred at 65° C for 1 h and then was cooled to room temperature.
There was added 40 mL of 10percent aqueous HCl and the reaction mixture was diluted with ethyl acetate and the layers were separated.
The organic layer was washed with brine, dried (MgSO4) and concentrated in vacuo to afford 3.2 g (96percent) of the title compound, which was sufficiently pure to be used without purification. MS (NH3-CI) 218.3 (M+H)+.
96% With hydrogenchloride In tetrahydrofuran; mineral oil Part A.
Preparation of ethyl 3-(3-cyanophenyl)-3-oxopropionate.
To a suspension of sodium hydride (1.2 g of 60percent suspension in mineral oil, hexane-washed, 30.3 mmol) in 40 mL of tetrahydrofuran was added diethyl carbonate (3.7 mL, 30.3 mmol) and 3-acetyl benzonitrile (2.2 g, 15.2 mmol).
The resulting suspension was stirred at 65° C. for 1 h and then was cooled to room temperature.
There was added 40 mL of 10percent aqueous HCl and the reaction mixture was diluted with ethyl acetate and the layers were separated.
The organic layer was washed with brine, dried (MgSO4) and concentrated in vacuo to afford 3.2 g (96percent) of the title compound, which was sufficiently pure to be used without purification. MS (NH3-CI) 218.3 (M+H)+.
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 6, p. 1910 - 1915
[2] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 5, p. 641 - 645
[3] Patent: WO2011/46774, 2011, A1, . Location in patent: Page/Page column 16
[4] Patent: EP946528, 2003, B1,
[5] Patent: US6187797, 2001, B1,
  • 2
  • [ 6136-68-1 ]
  • [ 21860-07-1 ]
Reference: [1] Chemische Berichte, 1900, vol. 33, p. 3409
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 6136-68-1 ]

Aryls

Chemical Structure| 32446-66-5

[ 32446-66-5 ]

4,4'-Dicyanobenzophenone

Similarity: 0.95

Chemical Structure| 1503-49-7

[ 1503-49-7 ]

4-Benzoylbenzonitrile

Similarity: 0.95

Chemical Structure| 90401-84-6

[ 90401-84-6 ]

6-Cyano-1-tetralone

Similarity: 0.92

Chemical Structure| 25724-79-2

[ 25724-79-2 ]

2,3-Dihydro-1-oxo-1H-indene-5-carbonitrile

Similarity: 0.92

Chemical Structure| 69975-66-2

[ 69975-66-2 ]

3-Oxo-indan-5-carbonitrile

Similarity: 0.92

Ketones

Chemical Structure| 32446-66-5

[ 32446-66-5 ]

4,4'-Dicyanobenzophenone

Similarity: 0.95

Chemical Structure| 1503-49-7

[ 1503-49-7 ]

4-Benzoylbenzonitrile

Similarity: 0.95

Chemical Structure| 90401-84-6

[ 90401-84-6 ]

6-Cyano-1-tetralone

Similarity: 0.92

Chemical Structure| 25724-79-2

[ 25724-79-2 ]

2,3-Dihydro-1-oxo-1H-indene-5-carbonitrile

Similarity: 0.92

Chemical Structure| 69975-66-2

[ 69975-66-2 ]

3-Oxo-indan-5-carbonitrile

Similarity: 0.92

Nitriles

Chemical Structure| 32446-66-5

[ 32446-66-5 ]

4,4'-Dicyanobenzophenone

Similarity: 0.95

Chemical Structure| 1503-49-7

[ 1503-49-7 ]

4-Benzoylbenzonitrile

Similarity: 0.95

Chemical Structure| 90401-84-6

[ 90401-84-6 ]

6-Cyano-1-tetralone

Similarity: 0.92

Chemical Structure| 25724-79-2

[ 25724-79-2 ]

2,3-Dihydro-1-oxo-1H-indene-5-carbonitrile

Similarity: 0.92

Chemical Structure| 69975-66-2

[ 69975-66-2 ]

3-Oxo-indan-5-carbonitrile

Similarity: 0.92